ArticleHeliyon2020

MiR-502 is the first reported miRNA simultaneously targeting two components of the classical non-homologous end joining (C-NHEJ) in pancreatic cell lines.

Agnieszka Smolinska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.